$DOMH
Dominari Holdings Inc. Stock $domh

$domh Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023083907 Filed on November 06, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$1.005M	$963.0K	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$6.858M	$4.070M	$4.515M
YoY Change	119.81%	-9.86%	169.39%
% of Gross Profit
Research & Development	-$6.000K		$61.00K
YoY Change	-120.0%		-40.78%
% of Gross Profit
Depreciation & Amortization	$23.00K	$30.00K
YoY Change
% of Gross Profit
Operating Expenses	$6.852M	$4.067M	$5.101M
YoY Change	118.22%	-20.27%	186.73%
Operating Profit		-$3.104M	-$5.101M
YoY Change		-39.15%	186.73%
Interest Expense	$1.931M	-$440.0K	-$1.138M
YoY Change	-146.98%	-61.34%	-165.7%
% of Operating Profit
Other Income/Expense, Net	-$3.000M	-$437.0K	-$1.138M
YoY Change		-61.6%
Pretax Income	-$6.916M	-$3.540M	-$6.239M
YoY Change	-4.74%	-43.26%	13174.47%
Income Tax
% Of Pretax Income
Net Earnings	-$6.916M	-$3.541M	-$6.239M
YoY Change	-4.74%	-43.24%	13174.47%
Net Earnings / Revenue	-688.16%	-367.71%
Basic Earnings Per Share		-$0.66	-$1.17
Diluted Earnings Per Share	-$1.27	-$0.66	-$1.17
COMMON SHARES
Basic Shares Outstanding	5.345M shares	5.345M shares	5.247M shares
Diluted Shares Outstanding		5.345M shares	5.345M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.38M	$20.66M	$35.40M
YoY Change	-59.36%	-41.62%	-63.57%
Cash & Equivalents	$2.833M	$4.388M	$34.50M
Short-Term Investments	$13.55M	$16.27M	$899.0K
Other Short-Term Assets	$8.585M	$7.900M	$693.0K
YoY Change	853.89%	1039.97%	7.61%
Inventory
Prepaid Expenses
Receivables	$3.177M	$6.300M	$8.645M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$28.14M	$34.89M	$56.09M
YoY Change	-44.44%	-37.81%	-42.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.679M	$361.0K	$708.0K
YoY Change		-49.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$24.15M	$22.70M	$26.09M
YoY Change	4.55%	-12.99%	414.98%
Other Assets	$458.0K	$500.0K	$458.0K
YoY Change	-8.4%	9.17%
Total Long-Term Assets	$29.42M	$28.32M	$28.36M
YoY Change	15.0%	-0.12%	295.3%
TOTAL ASSETS
Total Short-Term Assets	$28.14M	$34.89M	$56.09M
Total Long-Term Assets	$29.42M	$28.32M	$28.36M
Total Assets	$57.56M	$63.21M	$84.45M
YoY Change	-24.5%	-25.15%	-19.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.036M	$300.0K	$518.0K
YoY Change	159.0%	-42.08%	-67.05%
Accrued Expenses	$549.0K	$1.200M	$1.381M
YoY Change	-57.77%	-13.11%	482.7%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.607M	$1.722M	$1.899M
YoY Change	-10.17%	-9.32%	4.98%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.028M	$3.100M	$701.0K
YoY Change	332.57%	342.23%
Total Long-Term Liabilities	$3.028M	$3.100M	$701.0K
YoY Change	332.57%	342.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.607M	$1.722M	$1.899M
Total Long-Term Liabilities	$3.028M	$3.100M	$701.0K
Total Liabilities	$4.635M	$4.859M	$2.600M
YoY Change	87.73%	86.88%	43.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$208.8M	-$201.8M	-$178.6M
YoY Change	12.31%	13.0%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$501.0K	$501.0K	$2.501M
YoY Change	-84.92%	-79.97%
Treasury Stock Shares			345.0K shares
Shareholders Equity	$52.92M	$58.35M	$81.85M
YoY Change
Total Liabilities & Shareholders Equity	$57.56M	$63.21M	$84.45M
YoY Change	-24.5%	-25.15%	-19.56%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$6.916M	-$3.541M	-$6.239M
YoY Change	-4.74%	-43.24%	13174.47%
Depreciation, Depletion And Amortization	$23.00K	$30.00K
YoY Change
Cash From Operating Activities	-$4.742M	-$3.580M	-$2.863M
YoY Change	154.95%	25.04%	50.92%
INVESTING ACTIVITIES
Capital Expenditures	$7.000K	$0.00	-$525.0K
YoY Change	-99.46%	-100.0%	17400.0%
Acquisitions
YoY Change
Other Investing Activities	$3.197M	$4.370M	-$156.0K
YoY Change	20.19%	-2901.28%	-220.0%
Cash From Investing Activities	$3.190M	$4.360M	-$681.0K
YoY Change	134.56%	-740.23%	-636.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.000K	0.000	-751.0K
YoY Change	-100.12%	-100.0%
NET CHANGE
Cash From Operating Activities	-4.742M	-3.580M	-2.863M
Cash From Investing Activities	3.190M	4.360M	-681.0K
Cash From Financing Activities	1.000K	0.000	-751.0K
Net Change In Cash	-1.551M	780.0K	-4.295M
YoY Change	17.5%	-118.16%	142.66%
FREE CASH FLOW
Cash From Operating Activities	-$4.742M	-$3.580M	-$2.863M
Capital Expenditures	$7.000K	$0.00	-$525.0K
Free Cash Flow	-$4.749M	-$3.580M	-$2.338M
YoY Change	50.28%	53.12%	23.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent		usd
	us-gaap	Revenues Revenues		usd
CY2023Q3	us-gaap	Other Income OtherIncome		usd
CY2023Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.66
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5159501	shares
	dei	Trading Symbol TradingSymbol	DOMH
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5345312	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4388000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33174000	usd
CY2023Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	16274000	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41845
	dei	Entity Registrant Name EntityRegistrantName	DOMINARI HOLDINGS INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-0849320
	dei	Entity Address Address Line1 EntityAddressAddressLine1	725 5th Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	22nd Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
	dei	City Area Code CityAreaCode	(212)
	dei	Local Phone Number LocalPhoneNumber	393-4540
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	7130000	usd
CY2023Q3	domh	Clearing Broker Deposits ClearingBrokerDeposits	7172000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	715000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	564000	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	301000	usd
CY2023Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	1000	usd
CY2022Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	13000	usd
CY2023Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	6336000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	7474000	usd
CY2022Q4	domh	Investment In Field Point Securitie InvestmentInFieldPointSecuritie	2000000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	34886000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	50656000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	361000	usd
CY2023Q3	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1372000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1100000	usd
CY2023Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	7000	usd
CY2023Q3	us-gaap	Long Term Investments LongTermInvestments	22696000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	23103000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3426000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	919000	usd
CY2023Q3	us-gaap	Security Deposit SecurityDeposit	458000	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	458000	usd
CY2023Q3	us-gaap	Assets Assets	63206000	usd
CY2022Q4	us-gaap	Assets Assets	76236000	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	315000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	447000	usd
CY2023Q3	domh	Accrued Salaries And Benefit AccruedSalariesAndBenefit	632000	usd
CY2022Q4	domh	Accrued Salaries And Benefit AccruedSalariesAndBenefit	1260000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	177000	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	411000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	82000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	187000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1722000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1789000	usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3137000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	680000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	4859000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2469000	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5345312	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5485096	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5285164	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5017079	shares
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	260695000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	262970000	usd
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	60148	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	468017	shares
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	501000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3322000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-201847000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-185881000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	58347000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	73767000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	63206000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	76236000	usd
CY2023Q3	us-gaap	Revenues Revenues	963000	usd
	us-gaap	Revenues Revenues	1034000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4067000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4515000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16980000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8564000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	61000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2113000	usd
CY2022Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	525000	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	525000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	4067000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	5101000	usd
	us-gaap	Operating Expenses OperatingExpenses	16983000	usd
	us-gaap	Operating Expenses OperatingExpenses	11202000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3104000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5101000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15949000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11202000	usd
	us-gaap	Other Income OtherIncome	64000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	208000	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	187000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	505000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	586000	usd
CY2023Q3	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-150000	usd
CY2022Q3	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-1654000	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	185000	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-4390000	usd
	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	-212000	usd
CY2023Q3	domh	Change In Fair Value Of Investments ChangeInFairValueOfInvestments	495000	usd
CY2022Q3	domh	Change In Fair Value Of Investments ChangeInFairValueOfInvestments	-329000	usd
	domh	Change In Fair Value Of Investments ChangeInFairValueOfInvestments	495000	usd
	domh	Change In Fair Value Of Investments ChangeInFairValueOfInvestments	-91000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-437000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1138000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3649000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3541000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-6239000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15966000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14851000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4109000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3541000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6239000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15966000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18960000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.66
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.59
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5345312	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5344989	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5159501	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5283182	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	61778000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	110000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3541000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	58347000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	87467000	usd
CY2022Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	751000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1370000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-6239000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	81847000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	73767000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1485000	usd
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	939000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15966000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	58347000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	101595000	usd
	domh	Deemed Dividends Related To Series O And Series P Redeemable Convertible Preferred Stock DeemedDividendsRelatedToSeriesOAndSeriesPRedeemableConvertiblePreferredStock	-4109000	usd
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2237000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1475000	usd
	us-gaap	Adjustments To Additional Paid In Capital Stock Split AdjustmentsToAdditionalPaidInCapitalStockSplit	26000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14851000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	81847000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15966000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14851000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	268000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	23000	usd
	us-gaap	Depreciation Depreciation	57000	usd
	domh	Change In Fair Value Of Shortterm Investment ChangeInFairValueOfShorttermInvestment	12000	usd
	domh	Change In Fair Value Of Shortterm Investment ChangeInFairValueOfShorttermInvestment	1517000	usd
	domh	Change In Fair Value Of Longterm Investment ChangeInFairValueOfLongtermInvestment	482000	usd
	domh	Change In Fair Value Of Longterm Investment ChangeInFairValueOfLongtermInvestment	-1608000	usd
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	525000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1485000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1475000	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-1249000	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-712000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	897000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-3889000	usd
	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	-212000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	229000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	344000	usd
	domh	Increase Decrease In Prepaid Acquisition Cost IncreaseDecreaseInPrepaidAcquisitionCost	-301000	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-3622000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-345000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	137000	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-628000	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	659000	usd
	domh	Increase Decrease In Accrued Commissions IncreaseDecreaseInAccruedCommissions	152000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	11000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	12000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	66000	usd
	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	96000	usd
	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	521000	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	295000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17488000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8670000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	34068000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	27479000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	24572000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	28503000	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	93000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	419000	usd
	domh	Return Of Depositfunding Of Deposit Into A Managed Account Net ReturnOfDepositfundingOfDepositIntoAManagedAccountNet	1112000	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	850000	usd
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	107000	usd
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	525000	usd
	domh	Purchaseofshort Termandlong Terminvestments Purchaseofshort-termandlong-terminvestments	75000	usd
	domh	Purchaseofshort Termandlong Terminvestments Purchaseofshort-termandlong-terminvestments	15016000	usd
	domh	Purchase Of Shortterm And Longterm Promissory Notes PurchaseOfShorttermAndLongtermPromissoryNotes	1600000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10359000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16024000	usd
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	17891000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	26000	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	-22000000	usd
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	939000	usd
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	2237000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-939000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6372000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-28786000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-31066000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33174000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	65562000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4388000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34496000	usd
	domh	Transfer From Longterm Investment To Marketable Securites TransferFromLongtermInvestmentToMarketableSecurites	1497000	usd
	domh	Reclassify From Convertible Note Receivable To Notes Receivable At Fair Value ReclassifyFromConvertibleNoteReceivableToNotesReceivableAtFairValue	2147000	usd
	domh	Promissory Convertible Note Receivable Conversion Into Common Shares PromissoryConvertibleNoteReceivableConversionIntoCommonShares	899000	usd
	us-gaap	Stock Issued1 StockIssued1	3112000	usd
	domh	Less Deposit Previously Transferred In October2022 To Fps LessDepositPreviouslyTransferredInOctober2022ToFPS	2000000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1112000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P7Y
CY2023Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	12874	usd
	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	13502	usd
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P7Y
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"><i>Use of Estimates</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include stock-based compensation, the valuation of investments, the valuation of notes receivable and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.</span></p>
CY2023Q3	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	7200000	usd
CY2022Q3	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	49368	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	51868	usd
CY2023Q3	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P5Y
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	188000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	747000	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	3400000	usd
CY2023Q3	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	762000	usd
CY2022Q3	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	144000	usd
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	1249000	usd
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	712000	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	382000	usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1589000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	897000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3889000	usd
CY2023Q3	us-gaap	Dividend Income Operating DividendIncomeOperating	230000	usd
CY2022Q3	us-gaap	Dividend Income Operating DividendIncomeOperating	79000	usd
	us-gaap	Dividend Income Operating DividendIncomeOperating	537000	usd
	us-gaap	Dividend Income Operating DividendIncomeOperating	211000	usd
CY2023Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-150000	usd
CY2022Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1654000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	185000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-4390000	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	1000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	13000	usd
CY2023Q3	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	20922000	usd
CY2023Q3	us-gaap	Long Term Investments LongTermInvestments	22696000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	23103000	usd
CY2023Q3	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	1800000	usd
CY2023Q3	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	250000	usd
	us-gaap	Interest Income Other InterestIncomeOther	200000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2023Q3	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	16274000	usd
CY2023Q3	us-gaap	Marketable Securities MarketableSecurities	16274000	usd
CY2023Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	1000	usd
CY2023Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	6336000	usd
CY2023Q3	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1372000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	7130000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	7130000	usd
CY2022Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	13000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	7474000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1100000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3426000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	411000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3137000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3548000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y8M12D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
	us-gaap	Lease Cost LeaseCost	600000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	179000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	490000	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	179000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	490000	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	33000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	96000	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	212000	usd
	us-gaap	Lease Cost LeaseCost	586000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	209000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2780000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	685000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	685000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	685000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	766000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1160000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4916000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1368000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3548000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	675593	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	643404	shares
CY2023Q1	domh	Shares Cancelled SharesCancelled	644499	shares
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	644499	shares
CY2023Q1	domh	Shares Cancelled SharesCancelled	25000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	2700000	usd
CY2023Q2	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	503876	shares
CY2023Q2	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	1300000	usd
CY2022Q1	us-gaap	Program Rights Obligations ProgramRightsObligations	3000000	usd
CY2023Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	236630	shares
CY2023Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	3.97
CY2023Q1	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	644499	shares
CY2023Q1	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	3800000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	8068	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.9
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	626024	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.67
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	537783	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	2.63
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	96309	shares
CY2023Q3	domh	Weighted Average Grant Day Fair Value Ending Balancein Dollars WeightedAverageGrantDayFairValueEndingBalanceinDollars	3.18
	us-gaap	Restricted Stock Expense RestrictedStockExpense	93000	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	1400000	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	200000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	31193	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	302.97
CY2022Q4	domh	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractual	P7Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	110000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.21
	domh	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Granted Weighted Average Remaining Contractual SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsGrantedWeightedAverageRemainingContractual	P9Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5882	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.95
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	857	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	9719.07
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	134454	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.7
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y4M24D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	24454	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	44.43
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y1M6D
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	700000	usd
CY2023Q3	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	318000	usd
	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	361000	usd
CY2023Q3	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	525000	usd
	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	539000	usd
CY2023Q3	us-gaap	Payments For Merger Related Costs PaymentsForMergerRelatedCosts	72000	usd
	us-gaap	Payments For Merger Related Costs PaymentsForMergerRelatedCosts	72000	usd
CY2023Q3	us-gaap	Noninterest Income Other NoninterestIncomeOther	48000	usd
	us-gaap	Noninterest Income Other NoninterestIncomeOther	62000	usd
CY2023Q3	us-gaap	Revenues Revenues	963000	usd
	us-gaap	Revenues Revenues	1034000	usd
CY2023Q3	us-gaap	Excess Capital ExcessCapital	6100000	usd
CY2023Q3	us-gaap	Capital Units Net Amount CapitalUnitsNetAmount	100000	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	75000000000	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	800000	usd
CY2022Q4	domh	Clearing Broker Deposits ClearingBrokerDeposits		usd
CY2023Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2023Q3	domh	Investment In Field Point Securitie InvestmentInFieldPointSecuritie		usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent		usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2023Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense		usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense		usd
CY2022Q3	us-gaap	Other Income OtherIncome		usd
	us-gaap	Other Income OtherIncome		usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable		usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable		usd
	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable		usd
CY2022Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.59
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5283182	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5344989	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5345312	shares
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
	us-gaap	Treasury Stock Retired Par Value Method Amount TreasuryStockRetiredParValueMethodAmount		usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued		usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
	domh	Redemption Of Series P Redeemable Convertible Preferred Stock RedemptionOfSeriesPRedeemableConvertiblePreferredStock		usd
	domh	Cancellation Of Common Stock Related To Investment In Cb Min Shares CancellationOfCommonStockRelatedToInvestmentInCBMinShares		usd
	us-gaap	Depreciation Depreciation		usd
	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable		usd
	domh	Increase Decrease In Prepaid Acquisition Cost IncreaseDecreaseInPrepaidAcquisitionCost		usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits		usd
	domh	Increase Decrease In Accrued Commissions IncreaseDecreaseInAccruedCommissions		usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities		usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
	domh	Return Of Depositfunding Of Deposit Into A Managed Account Net ReturnOfDepositfundingOfDepositIntoAManagedAccountNet		usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable		usd
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		usd
	domh	Purchase Of Shortterm And Longterm Promissory Notes PurchaseOfShorttermAndLongtermPromissoryNotes		usd
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
	domh	Transfer From Longterm Investment To Marketable Securites TransferFromLongtermInvestmentToMarketableSecurites		usd
	domh	Reclassify From Convertible Note Receivable To Notes Receivable At Fair Value ReclassifyFromConvertibleNoteReceivableToNotesReceivableAtFairValue		usd
	domh	Promissory Convertible Note Receivable Conversion Into Common Shares PromissoryConvertibleNoteReceivableConversionIntoCommonShares		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
	domh	Sharebased Compensation Shares Authorized Under Stock Option Plans Forfeited Price Range Outstanding Options Granted Weighted Average Remaining Contractual SharebasedCompensationSharesAuthorizedUnderStockOptionPlansForfeitedPriceRangeOutstandingOptionsGrantedWeightedAverageRemainingContractual
CY2023Q3	domh	Share Based Compensation Arrangement By Share Based Payment Award Options Expired Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredOutstandingIntrinsicValue		usd
	domh	Sharebased Compensation Shares Authorized Under Stock Option Expired Plans Forfeited Price Range Outstanding Options Granted Weighted Average Remaining Contractual SharebasedCompensationSharesAuthorizedUnderStockOptionExpiredPlansForfeitedPriceRangeOutstandingOptionsGrantedWeightedAverageRemainingContractual
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
CY2022Q3	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss		usd
	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss		usd
CY2022Q3	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue		usd
	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue		usd
CY2022Q3	us-gaap	Noninterest Income Other NoninterestIncomeOther		usd
	us-gaap	Noninterest Income Other NoninterestIncomeOther		usd
CY2022Q3	us-gaap	Revenues Revenues		usd
	us-gaap	Revenues Revenues		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0000012239

Files In Submission

Name	View Source	Status
0001213900-23-083907-index-headers.html	Edgar Link	pending
0001213900-23-083907-index.html	Edgar Link	pending
0001213900-23-083907.txt	Edgar Link	pending
0001213900-23-083907-xbrl.zip	Edgar Link	pending
domh-20230930.xsd	Edgar Link	pending
f10q0923ex31-1_dominari.htm	Edgar Link	pending
f10q0923ex31-2_dominari.htm	Edgar Link	pending
f10q0923ex32-1_dominari.htm	Edgar Link	pending
f10q0923ex32-2_dominari.htm	Edgar Link	pending
f10q0923_dominari.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
domh-20230930_lab.xml	Edgar Link	unprocessable
f10q0923_dominari_htm.xml	Edgar Link	completed
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
domh-20230930_cal.xml	Edgar Link	unprocessable
domh-20230930_def.xml	Edgar Link	unprocessable
domh-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DOMH
Dominari Holdings Inc. Stock $domh

2023 Q4 Form 10-Q Financial Statement

#000121390023083907 Filed on November 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOMH Dominari Holdings Inc. Stock $domh

2023 Q4 Form 10-Q Financial Statement

#000121390023083907 Filed on November 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOMH
Dominari Holdings Inc. Stock $domh